Vertex Pharmaceuticals and the Cystic Fibrosis Foundation: Venture Philanthropy Funding for Biotech

Source: 
Harvard Business School

Date

2010

Case Study Sector

Management

In 2001, Vertex Pharmaceuticals Incorporated acquired the San Diego-based biotech company Aurora Biosciences. The combination of Vertex's and Aurora's technologies would improve the flow of novel drug candidates into development. However, several questions related to the integration of Aurora into Vertex were still unresolved, the most pressing being Aurora's major collaboration with the Cystic Fibrosis Foundation (CFF). Were venture philanthropy and foundation deals an appropriate funding mechanism for a public company like Vertex? How could the board of Vertex and the CFF fundamentally align the objectives of a for-profit company with those of a non-profit institution? Those were the questions faced by the Vertex executives.

Link

Keyword

  • Field Building
  • Strategy

Region

  • Northern America

Blog Posts

More on time, value, and time limits

April 3, 2017

A new report applies a theory of time and value in philanthropy to three real cases, to see how a foundation could decide whether to operate with a limited life, based on the amount and kind of value it hopes to create.

Events

Oct 05

Rip Rapson
President and CEO
The Kresge Foundation